Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: A systematic review and meta-analysis

Human Reproduction Update

Volumn 20, Issue 5, 2014, Pages 748-758

  Barry, John A ^a   Azizia, Mallika M ^a   Hardiman, Paul J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Breast; Endometrium; Menopause; Ovarian cancer; Polycystic ovary syndrome

Indexed keywords

BREAST CANCER; CANCER RISK; ENDOMETRIUM CANCER; HIGH RISK POPULATION; HUMAN; OVARY CANCER; OVARY POLYCYSTIC DISEASE; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC REVIEW;

BREAST; ENDOMETRIUM; MENOPAUSE; OVARIAN CANCER; POLYCYSTIC OVARY SYNDROME;

BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; OVARIAN NEOPLASMS; POLYCYSTIC OVARY SYNDROME; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 84905082203     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmu012     Document Type: Review

References (53)

1. Anderson KE, Sellers TA, Chen PL, Rich SS, Hong CP, Folsom AR. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer 1997;79:494-499.
2. Azziz R,Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-2749.
3. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91:4237-4245.
4. Baron JA, Weiderpass E, Newcomb PA, Stampfer M, Titus-Ernstoff L, Egan KM, Greenberg ER. Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 2001;12:875-880.
5. Bodmer M, Becker C, Meier C, Jick SS, Meier CR. Use of metformin and the risk of ovarian cancer: a case-control analysis. Gynecol Oncol 2011;123:200-204.
6. Birks S, Peeters A, Backholer K, O'Brien P, Brown W. Asystematic reviewof the impact of weight loss on cancer incidence and mortality. Obes Rev 2012;13:868-891.
7. Broekmans FJ, Knauff EAH, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BCJM. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006;113: 1210-1217.
8. Cancer Research UK. 2013. Cancer statistics by type. Available on the world wide web at http://www.cancerresearchuk.org/cancer-info/cancerstats/types/ (26 February 2014, date last accessed).
9. Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online 2009;19:398-405.
10. Clayton RN, Ogden V, Hodgkinson J, Worswick L, Rodin DA, Dyer S, Meade TW. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol (Oxf) 1992;37:127-134.
11. Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61:403-407.
12. Dahlgren E, Friberg LG, Johansson S, Lindstrom B, Oden A, Samsioe G, Janson PO. Endometrial carcinoma; ovarian dysfunction-a risk factor in young women. Eur J Obstet Gynecol Reprod Biol 1991;41:143-150.
13. Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 2007;18:280-285.
14. Dockerty MB, Jackson RL. The Stein-Leventhal syndrome: analysis of 43 cases with special reference to association with endometrial carcinoma. Am J Obstet Gynecol 1957;73:161-173.
15. Dockerty MB, Lovelady SB, Foust GT Jr. Carcinoma of the corpus uteri in young women. Am J Obstet Gynecol 1951;61:966-981.
16. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800.
17. Escobedo LG, Lee NC, Peterson HB, Wingo PA. Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol 1991;77:124-128.
18. ESHRE/ASRM. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
19. Fearnley EJ, Marquart L, Spurdle AB, Weinstein P, Webb PM. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study. Cancer Causes Control 2010;21:2303-2308.
20. Gadducci A, Gargini A, Palla E, Fanucchi A, Genazzani AR. Polycystic ovary syndrome and gynecological cancers: is there a link? Gynecol Endocrinol 2005;20:200-208.
21. Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 1984;64:417-420. Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol 1991;134:818-824.
22. Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol 1991;134:818-824.
23. Genazzani AR,Gadducci A,Gambacciani M. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera delDuomo, Pisa, Italy. Climacteric 2001;4:181-193.
24. Ghasemi N, Mortazavizadeh MR, Khorasani Gerdekoohi A. Frequency of poly cystic ovary syndrome in patients with premenopausal breast cancer. Iran J Reprod Med 2012;8:86-89.
25. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review.AmJ Clin Nutr 2007;86:s836-s842.
26. Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod 2012;27:1327-1331.
27. Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003;361:1810-1812.
28. Iatrakis G, Zervoudis S, Saviolakis A, Troulos M, Antoniou E, Sarantaki A, Lykeridou K, Kourounis G. Women younger than 50 years with endometrial cancer. Eur J Gynaecol Oncol 2006;27:399-400.
29. Jafari K, Javaheri G, Ruiz G. Endometrial adenocarcinoma and the Stein-Leventhal syndrome. Obstet Gynecol 1978;51:97-100.
30. Key TJ, Pike MC. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988;57:205-212.
31. Kurabayashi T, Kase H, Suzuki M, Sugaya S, Fujita K, Tanaka K. Endometrial abnormalities in infertile women. J Reprod Med 2003;48:455-459.
32. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977;33:363-374.
33. LandmanGW, KleefstraN, van Hateren KJ, Groenier KH, Gans RO, Bilo HJ. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care 2009;33:322-326.
34. Legro R. InDiamanti-Kandarakis E,Nestler J,PanidisD,PasqualiR, (eds). Insulin resistance and polycystic ovarian syndrome 2007. Humana Press, Totowa, NJ, 335-348.
35. Lunde O, Tanbo T. Polycystic ovary syndrome: a follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15-25 years after ovarian wedge resection. Gynecol Endocrinol 2007;23:704-709.
36. Niwa K, Imai A, Hashimoto M, Yokoyama Y, Mori H, Matsuda Y, Tamaya T. A case-control study of uterine endometrial cancer of pre- and post-menopausal women. Oncol Rep 2000;7:89-93.
37. Olsen CM, Green AC, Nagle CM, Jordan SJ, Whiteman DC, Bain CJ, Webb PM. Epithelial ovarian cancer: testing the 'androgens hypothesis'. Endocr Relat Cancer 2008;15:1061-1068.
38. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 1998; 51:581-586.
39. Pillay OC, Te Fong LF, Crow JC, Benjamin E, Mould T, Atiomo W, Menon PA, Leonard AJ, Hardiman P. The association between polycystic ovaries and endometrial cancer. Hum Reprod 2006;21:924-929.
40. PolsonDW, Adams J,Wadsworth J, Franks S. Polycystic ovaries-a common finding in normal women. Lancet 1988;1:870-872.
41. RCOG. Polycystic Ovary Syndrome, Long-Term Consequences. Green-top Guideline No. 33. 2007. Royal College of Obstetricians and Gynaecologists, London.
42. Reeves BDJ, Higgins J. Cochrane handbook for systematic reviews of interventions. In: Higgins JPT, Green S (ed). The Cochrane Collaboration, London, UK. 2011.
43. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-578.
44. Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A, Hughes C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 1996; 88:554-559.
45. Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril 2007;88:1389-1395.
46. Solomon CG. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. Endocrinol Metab Clin North Am 1999;28:247-263.
47. Speert H. Carcinoma of the endometrium in young women. Surg Gynecol Obstet 1949; 88:332-336.
48. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.
49. Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C. Selected medical conditions and risk of breast cancer. Br J Cancer 1997;75:1699-1703.
50. Webb PM. Obesity and gynecologic cancer etiology and survival.AmSoc Clin Oncol Educ Book 2013; 222-228.
51. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011. www.ohri.ca/programs/clinical_epidemiology/ oxford_web.ppt.
52. Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb) 2000; 3:101-105.
53. Zucchetto A, Serraino D, Polesel J, Negri E, De Paoli A, Dal Maso L, Montella M, La Vecchia C, Franceschi S, Talamini R. Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur J Cancer Prev 2009;18:316-321.